{"id":10918,"date":"2026-04-22T03:54:55","date_gmt":"2026-04-22T03:54:55","guid":{"rendered":"https:\/\/globalnewstoday.uk\/index.php\/2026\/04\/22\/home-healthcare-provider-viemed-schedules-q1-results-call-for-may-6-stock-titan\/"},"modified":"2026-04-22T03:54:55","modified_gmt":"2026-04-22T03:54:55","slug":"home-healthcare-provider-viemed-schedules-q1-results-call-for-may-6-stock-titan","status":"publish","type":"post","link":"https:\/\/globalnewstoday.uk\/index.php\/2026\/04\/22\/home-healthcare-provider-viemed-schedules-q1-results-call-for-may-6-stock-titan\/","title":{"rendered":"Home healthcare provider Viemed schedules Q1 results call for May 6 – Stock Titan"},"content":{"rendered":"

Kyverna Presents Registrational Trial Primary Analysis for Miv-ce…<\/a>
Revolution Medicines to Present Updated Phase 1\/2 Clinical Data f…<\/a>
Adobe Announces New $25 Billion Stock Repurchase Program<\/a>
National Healthcare Properties Announces Pricing of Public Offeri…<\/a>
Revolution Medicines to Present Preclinical Data on Innovative Mu…<\/a>
FST Corp. Announces 31% Revenue Increase, Bottom Line Improvement…<\/a>
Kyverna Presents Registrational Trial Primary Analysis for Miv-ce…<\/a>
Revolution Medicines to Present Updated Phase 1\/2 Clinical Data f…<\/a>
Adobe Announces New $25 Billion Stock Repurchase Program<\/a>
National Healthcare Properties Announces Pricing of Public Offeri…<\/a>
Revolution Medicines to Present Preclinical Data on Innovative Mu…<\/a>
FST Corp. Announces 31% Revenue Increase, Bottom Line Improvement…<\/a>
Viemed Healthcare (NASDAQ:VMD)<\/b> will host its First Quarter 2026 earnings conference call on Wednesday, May 6, 2026 at 11:00 a.m. EDT<\/b>. Interested parties may dial provided numbers or listen via live webcast; a replay will be posted in the Investor Relations section at www.viemed.com.
VMD slipped 0.82%<\/b> while scanner data shows only INGN<\/b> in momentum, up about 2%<\/b> without news. Other close peers show mixed day-to-day moves, pointing to stock-specific rather than sector-driven trading.
Past earnings call scheduling headlines for VMD typically saw small, modestly positive or flat price reactions, indicating these notices have been routine informational events.
Over the last several quarters, Viemed has regularly announced earnings conference call logistics, including Q3 and Q2 2025<\/b>, Q1 2025<\/b>, and year-end 2024<\/b> updates. Price reactions around these call-detail press releases were modest, with moves between 0%<\/b> and roughly 1.3%<\/b>. Today\u2019s First Quarter 2026<\/b> call announcement continues that pattern of routine investor communication without additional financial data.
In the past, VMD\u2019s earnings call detail notices under this tag produced an average move of 0.53%<\/b>, indicating today\u2019s First Quarter 2026 call announcement fits a well-established communication pattern.
Viemed has consistently scheduled quarterly and year-end earnings calls from 2024 through 2025, and the First Quarter 2026 call continues this structured cadence of financial reporting updates.
This announcement sets the schedule and access details for Viemed\u2019s First Quarter 2026<\/b> earnings call, without adding new financial metrics. Historically, similar call notices have produced modest price responses. Investors monitoring VMD may focus on previously disclosed 2026<\/b> guidance, recent insider filings, and prior record 2025<\/b> results, using the upcoming call to gauge operational trends and management\u2019s commentary on reimbursement and growth drivers.
AI-generated analysis. Not financial advice.
LAFAYETTE, LA \/ ACCESS Newswire<\/a> \/ April 21, 2026 \/ <\/strong>Viemed Healthcare, Inc. (the “Company<\/strong>” or “Viemed<\/strong>“) (NASDAQ:VMD<\/a>), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its First Quarter 2026 Earnings Conference Call on Wednesday, May 6, 2026, at 11:00 a.m. EDT.
Interested parties may participate in the call by dialing:<\/strong>
877-407-6176 (US Toll-Free)
+1 201-689-8451 (International)
Live Audio Webcast: <\/strong>https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=MWjE55eM<\/a>
Following the live call, a replay will be available in the Investor Relations section of the Company’s website at www.viemed.com<\/a>.
ABOUT VIEMED HEALTHCARE, INC.<\/strong>
Viemed is a provider of home medical equipment and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women’s health products and services. Viemed’s model emphasizes efficient, high-quality care delivered in the home through a combination of high-touch clinical support and technology-enabled services, including therapy, education, and counseling provided by our clinical practitioners. For more information, visit our website at www.viemed.com<\/a>.
For further information, please contact:
Investor Relations<\/strong>
ir@viemed.com<\/a>
Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
(337) 504-3802
SOURCE: <\/strong>Viemed Healthcare, Inc.
Continue reading with these related stories
\u00a9 2020-2026 StockTitan.net – Your Edge is Information
Information only. Not investment advice.<\/p>\n

source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Kyverna Presents Registrational Trial Primary Analysis for Miv-ce…Revolution Medicines to Present Updated Phase 1\/2 Clinical Data f…Adobe Announces New $25 Billion Stock Repurchase ProgramNational Healthcare Properties Announces Pricing of Public Offeri…Revolution Medicines to Present Preclinical Data on Innovative Mu…FST Corp. Announces 31% Revenue Increase, Bottom Line Improvement…Kyverna Presents Registrational Trial Primary Analysis for Miv-ce…Revolution Medicines […]<\/p>\n","protected":false},"author":1,"featured_media":10919,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":{"0":"post-10918","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business"},"_links":{"self":[{"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/posts\/10918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/comments?post=10918"}],"version-history":[{"count":0,"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/posts\/10918\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/media\/10919"}],"wp:attachment":[{"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/media?parent=10918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/categories?post=10918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/globalnewstoday.uk\/index.php\/wp-json\/wp\/v2\/tags?post=10918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}